To Invest or Not: Valeo Pharma (VPH.C) Reza Golzadeh November 11, 2021 In this episode, we revisit Valeo Pharma (VPH.C) to get an update on their product portfolio, stock price, and financials. Is VPH.C a good long term investment? Tune In! Golzadeh, Pharmaceuticals, Today's Analysis, Video Related Posts Valeo Pharma (VPH.C) gets their Hesperco flavonoid medicine on shelves with Loblaws brand Valeo Pharma Inc. (VPH.C) Enters PLA with Quebec Minister of Health Today’s Idea: Valeo Pharma (VPH.C) Boasts an Impressive Portfolio and Achieves Significant Growth Chart Attack: Valeo Pharma (VPH.C) Finds Buyers and Holds the Uptrend Valeo Pharma (VPH.C) – Investor Roundtable #3 Analysis: Valeo Pharma (VPH.C) down 34% YTD, sales over the last 12 months at $12 million More on VPH.C Valeo Pharma (VPH.C) gets their Hesperco flavonoid medicine on shelves with Loblaws brand Joseph Morton January 5, 2022 Valeo Pharma Inc. (VPH.C) Enters PLA with Quebec Minister of Health Kieran Robertson November 15, 2021 Today’s Idea: Valeo Pharma (VPH.C) Boasts an Impressive Portfolio and Achieves Significant Growth Kieran Robertson November 11, 2021 Chart Attack: Valeo Pharma (VPH.C) Finds Buyers and Holds the Uptrend Vishal Toora November 11, 2021 Valeo Pharma (VPH.C) – Investor Roundtable #3 Equity Guru November 11, 2021 Analysis: Valeo Pharma (VPH.C) down 34% YTD, sales over the last 12 months at $12 million Taku Ndachena November 11, 2021 Load More Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Name * Email * Website Comment * Save my name, email, and website in this browser for the next time I comment.
Valeo Pharma (VPH.C) gets their Hesperco flavonoid medicine on shelves with Loblaws brand Joseph Morton January 5, 2022
Valeo Pharma Inc. (VPH.C) Enters PLA with Quebec Minister of Health Kieran Robertson November 15, 2021
Today’s Idea: Valeo Pharma (VPH.C) Boasts an Impressive Portfolio and Achieves Significant Growth Kieran Robertson November 11, 2021
Analysis: Valeo Pharma (VPH.C) down 34% YTD, sales over the last 12 months at $12 million Taku Ndachena November 11, 2021